Department of Orthopaedic Surgery, University of Pittsburgh, PA 15213, USA.
Am J Sports Med. 2010 Dec;38(12):2477-86. doi: 10.1177/0363546510376750. Epub 2010 Aug 27.
Platelet-rich plasma (PRP) has been used to enhance tendon healing in clinical settings. However, the cellular mechanisms underlying PRP treatment of injured tendons remain unclear. The aim of this study was to determine the effects of PRP, in the form of PRP-clot releasate (PRCR), on tendon stem cells (TSCs), a newly discovered cell population in tendons.
The PRCR treatment promotes differentiation of TSCs into tenocytes that are activated to proliferate quickly and increase collagen production.
Controlled laboratory study.
After PRCR treatment, cell morphology, expression of stem/progenitor cell marker nucleostemin, and population doubling time were examined. In addition, gene and protein analyses were performed using reverse transcription-polymerase chain reaction, immunocytochemistry, and Western blot to characterize the type of cells that had differentiated after PRCR treatment.
The TSCs without PRCR treatment were small and exhibited an irregular shape, whereas with increasing PRCR dosage, TSCs became large, well spread, and highly elongated with downregulation of nucleostemin expression. The PRCR treatment also markedly enhanced TSC proliferation, tenocyte-related gene and protein expression, and total collagen production, all of which indicated that PRCR treatment induced differentiation of TSCs into activated tenocytes.
The PRCR treatment promotes differentiation of TSCs into active tenocytes exhibiting high proliferation rates and collagen production capability.
The findings of this study suggest that PRP treatment of injured tendons is "safe" as it promotes TSC differentiation into tenocytes rather than nontenocytes, which would compromise the structure and function of healing tendons by formation of nontendinous tissues. Moreover, they suggest that PRP treatment can enhance tendon healing because tenocytes induced to differentiate by PRP are activated to proliferate quickly and produce abundant collagen to repair injured tendons that have lost cells and matrix.
富含血小板的血浆(PRP)已被用于临床增强肌腱愈合。然而,PRP 治疗损伤肌腱的细胞机制仍不清楚。本研究旨在确定 PRP(PRP-凝块释放物 [PRCR])对肌腱干细胞(TSC)的影响,TSC 是肌腱中一种新发现的细胞群体。
PRCR 处理促进 TSC 分化为成纤维细胞,这些细胞被激活而快速增殖并增加胶原蛋白产生。
对照实验室研究。
在 PRCR 处理后,观察细胞形态、核干细胞标志物 nucleostemin 的表达和倍增时间。此外,通过逆转录-聚合酶链反应、免疫细胞化学和 Western blot 进行基因和蛋白质分析,以表征 PRCR 处理后分化的细胞类型。
未经 PRCR 处理的 TSC 体积小,形态不规则,而随着 PRCR 剂量的增加,TSC 体积增大,铺展良好,高度伸长,nucleostemin 表达下调。PRCR 处理还显著增强了 TSC 的增殖、成纤维细胞相关基因和蛋白质表达以及总胶原蛋白产生,这表明 PRCR 处理诱导 TSC 分化为激活的成纤维细胞。
PRCR 处理促进 TSC 分化为具有高增殖率和胶原蛋白产生能力的活跃成纤维细胞。
本研究结果表明,PRP 治疗损伤的肌腱是“安全的”,因为它促进 TSC 分化为成纤维细胞,而不是非成纤维细胞,否则会通过形成非腱组织而损害愈合的肌腱的结构和功能。此外,它们表明 PRP 治疗可以增强肌腱愈合,因为 PRP 诱导分化的成纤维细胞被激活而快速增殖并产生丰富的胶原蛋白来修复失去细胞和基质的损伤肌腱。